Topical Mupirocin Vs Traditional Dressing for Persistent Skin Ulcers: A Randomized Controlled Trial

Backgrounds: Mupirocin and traditional dressing are commonly used treatments that can aid in wound healing. This study aimed to investigate the use of mupirocin and traditional dressing in treating patients with chronic skin ulcers. Wounds are common injuries that require proper management and care to promote healing and prevent complications. Methods: The efficacy of mupirocin and traditional dressings in treating persistent skin ulcers are compared in this randomized controlled experiment. This study was authorized by the institutional ethics committee and before participating, each subject gave written informed permission. There were 60 participants in all, 16 of whom were female and 44 of whom were male. The study used descriptive statistics to analyze the data and recorded each patient’s gender, age group, hospital stays and wound surface area every week until four weeks. Results: Male patients (26) were treated with mupirocin more often than female patients, according to the results. Ten patients in the 51-60 age range received mupirocin treatment, the most of any group. In contrast, the highest number of patients treated with traditional dressing was in the under-40 age group with eight. The mean wound surface area for mupirocin wounds is consistently lower than the traditional dressing. Mupirocin had a shorter mean hospital stay of 32.10 days compared to the traditional dressing of 45.57 days. Conclusion: In terms of decreasing the surface area of wounds and minimizing hospital stays, Mupirocin may be more efficient than traditional wound dressings. These results could enhance clinical decision-making and improve patient outcomes in managing chronic skin ulcers.